1.64 Pharmacological and Nonpharmacological Treatments of Individuals With Fragile X Syndrome

Fragile X syndrome (FXS), caused by epigenetic silencing of the fragile X messenger ribonucleoprotein 1 (FMR1) gene, is associated with multiple neurobehavioral abnormalities that require pharmacological and nonpharmacological treatments. Here, we report on the frequency and type of such treatments for children with FXS.

https://www.jaacap.org/article/S0890-8567(22)01403-4/fulltext?rss=yes

Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2022 Category: Psychiatry Authors: Dejan B. Budimirovic, Dragana Protic, Dora Stojanovic, Catherine Eliades, Kristen Judy, Constance Smith-Hicks, Erika Augustine, Walter E. Kaufmann Source Type: research